Author

E. Morel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Belhadef· 1 shared A. Claude-Taupin· 1 shared A. Ferrino-Iriarte· 1 shared A. Llach· 1 shared A. Regnier· 1 shared A.-M. Gomez· 1 shared B. Crozatier· 1 shared C. Allende· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Belhadef

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

On the Role of VP3-PI3P Interaction in Birnavirus Endosomal Membrane Targeting

F. A. Zanetti, I. Fernandez, E. Baquero, P. Guardado-Calvo, A. Ferrino-Iriarte, S. Dubois, E. Morel, V. Alfonso, M. O. Aguilera, E. E. Celayes, L. M. Polo, L. Suhaiman, V. V. Galassi, M. V. Chiarpotti, C. Allende, , L. R. Delgui

This paper investigates how VP3 protein of birnaviruses targets endosomal membranes via PI3P binding, revealing a two-stage mechanism critical for viral replication.

bioRxiv · Feb 20, 2024Microbiology

YAP-dependent autophagy is controlled by AMPK, SIRT1 and flow intensity in kidney epithelial cells.

A. Claude-Taupin, F. Roccio, M. Garfa-Traore, A. Regnier, M. Burtin, E. Morel, F. Terzi, P. Codogno, N. Dupont

The paper shows YAP/TAZ inhibits autophagy in kidney epithelial cells under fluid flow, mediated by AMPK and SIRT1, and links this to CKD progression.

bioRxiv · Jan 9, 2023Cell Biology

EPAC1 Inhibition Protects the Heart from Doxorubicin-Induced Toxicity

M. Mazevet, A. Belhadef, M. Ribeiro, D. Dayde, A. Llach, M. Laudette, T. Belleville, P. Mateo, M. Gressette, F. Lefebvre, J. Chen, C. Bachelot-Loza, C. Rucker-Martin, F. Lezoualch, B. Crozatier, , E. Morel

This study shows that inhibiting EPAC1 protects the heart from doxorubicin-induced toxicity without affecting its cancer-killing effects.

bioRxiv · Jun 16, 2021Pathology